September 19, 2014 9:18 PM ET

Pharmaceuticals

Company Overview of Memory Pharmaceuticals Corp.

Company Overview

As of December 31, 2008, Memory Pharmaceuticals Corp. was acquired by Hoffmann-La Roche Inc. Memory Pharmaceuticals Corp. develops drugs for the treatment of central nervous system conditions. It offers drugs for neurological diseases associated with aging, such as Alzheimer’s disease, and psychiatric disorders, such as schizophrenia, cognitive impairment associated with schizophrenia (CIAS), and depression. The company’s products include MEM 1003, a neuronal L-type calcium channel modulator that is in phase II clinical trials for the treatment of Alzheimer’s disease and bipolar disorder; and nicotinic alpha-7 agonists, including MEM 3454, a phase IIa clinical trial product and MEM 63908, a ...

100 Philips Parkway

Montvale, NJ 07645

United States

Founded in 1997

55 Employees

Phone:

201-802-7100

Fax:

201-802-7190

Key Executives for Memory Pharmaceuticals Corp.

Memory Pharmaceuticals Corp. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
ProteoTech, Inc. United States
arGentis Pharmaceuticals, LLC United States
Serum Technologies Holdings, Inc. United States
Vital Nature LLC United States
EaglePicher Pharmaceutical Services LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Memory Pharmaceuticals Corp., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.